New drug tonabersat aims to reduce swelling in diabetic eye disease
NCT ID NCT05727891
First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 18 times
Summary
This study tests whether tonabersat can reduce retinal swelling in people with diabetic macular edema who still have good vision. About 128 adults with type 1 or 2 diabetes will receive either tonabersat or a placebo. The main goal is to see if the drug decreases the thickness of the central retina over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Boston Medical Center Corporation
Boston, Massachusetts, 02118, United States
-
Central Florida Retina Institute
Lakeland, Florida, 33805, United States
-
East Bay Retina Consultants, Inc.
Oakland, California, 94609, United States
-
Elman Retina Group
Baltimore, Maryland, 21237, United States
-
Florida Retina Consultants
Lakeland, Florida, 33805, United States
-
Hilton Head Retina Institute
Hilton Head Island, South Carolina, 29926, United States
-
Illinois Retina Associates
Oak Park, Illinois, 60304, United States
-
Joseph E. Humble and Raymond Haik PTRS DBA Eye Assoc of Northeast Louisiana
West Monroe, Louisiana, 71291, United States
-
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
-
Loma Linda University
Loma Linda, California, 92354, United States
-
Macula Retina Vitreous Institute
Torrance, California, 90503, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Midwest Eye Institute
Indianapolis, Indiana, 46290, United States
-
National Ophthalmic Research Institute
Fort Myers, Florida, 33912, United States
-
Pittsburg Clinical Trial Consortium
Sewickley, Pennsylvania, 15143, United States
-
Retina Associates of Southern California
Huntington Beach, California, 92647, United States
-
Retina Consultants of Texas, PA
Bellaire, Texas, 77401, United States
-
Retina Research Institute, LLC
St Louis, Missouri, 63128, United States
-
Retina-Vitreous Surgeons of Central NY, PC
Liverpool, New York, 13088, United States
-
Retinal Consultants of Texas
San Antonio, Texas, 78240, United States
-
Southeast Eye Institute, P.A. dba Eye Associates of Pinellas
Pinellas Park, Florida, 33782, United States
-
Southeast Retina Center
Augusta, Georgia, 30909, United States
-
Southern California Desert Retina Consultants, Inc.
Palm Desert, California, 92211, United States
-
Texas Retina Associates
Lubbock, Texas, 79424, United States
-
The Trustees of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Thomas Eye Group
Sandy Springs, Georgia, 30328, United States
-
University of Florida- Jacksonville
Jacksonville, Florida, 32209, United States
-
Verum Research LLC
Eugene, Oregon, 97401, United States
Conditions
Explore the condition pages connected to this study.